Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Delorme

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical and Laboratory Haematology|January 1, 1990
Sensitivity of the thrombin clotting time and activated partial thromboplastin time to low level of antithrombin III during heparin therapyM A Delorme, M J Inwood, B O'Keefe
Thrombosis and Haemostasis|May 1, 1996
The effects of dermatan sulfate at submicrogram/ml concentrations on in vitro thrombin generationM A Delorme, A S Tam, L Xu
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1990
Enteric-coated iron tabletsM A Delorme, M J Inwood, F Gwadry-Sridhar
DICP : the Annals of Pharmacotherapy|September 1, 1990
Prescribing and dispensing practices for oral iron tablets: a Canadian experienceM A Delorme, F H Gwadry-Sridhar, M J Inwood
Thrombosis Research|August 6, 1998
Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placentaM A Delorme, L Xu, L Berry, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin regulation in mother and fetus during pregnancyM A Delorme, R F Burrows, F A Ofosu, et al.
Blood|December 1, 1993
Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysisM A Delorme, N Saeed, A Sevcik, et al.
American Journal of Hematology|February 1, 1990
Orthotopic liver transplantation in a patient with combined hemophilia A and BM A Delorme, P C Adams, D Grant, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Laboratory Haematology|January 1, 1990
Sensitivity of the thrombin clotting time and activated partial thromboplastin time to low level of antithrombin III during heparin therapyM A Delorme, M J Inwood, B O'Keefe
Thrombosis and Haemostasis|May 1, 1996
The effects of dermatan sulfate at submicrogram/ml concentrations on in vitro thrombin generationM A Delorme, A S Tam, L Xu
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1990
Enteric-coated iron tabletsM A Delorme, M J Inwood, F Gwadry-Sridhar
DICP : the Annals of Pharmacotherapy|September 1, 1990
Prescribing and dispensing practices for oral iron tablets: a Canadian experienceM A Delorme, F H Gwadry-Sridhar, M J Inwood
Thrombosis Research|August 6, 1998
Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placentaM A Delorme, L Xu, L Berry, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin regulation in mother and fetus during pregnancyM A Delorme, R F Burrows, F A Ofosu, et al.
Blood|December 1, 1993
Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysisM A Delorme, N Saeed, A Sevcik, et al.
American Journal of Hematology|February 1, 1990
Orthotopic liver transplantation in a patient with combined hemophilia A and BM A Delorme, P C Adams, D Grant, et al.
Pageof 1